Non-thyroidal Illness Syndrome in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis

Bin Wang,Sui‐Jun Liu,Ling Li,Qiuming Yao,Ronghua Song,Xiaorong Shao,Qian Li,Xin Shi,Jin‐an Zhang
DOI: https://doi.org/10.1016/j.ijcard.2016.10.039
IF: 4.039
2017-01-01
International Journal of Cardiology
Abstract:Background Non-thyroidal illness syndrome (NTIS) is characterized by decreased serum triiodothyronine level without increased thyroid-stimulating hormone level during critical illness. The summary data on the prevalence of NTIS in cardiovascular patients are lacking, and its prognostic role in cardiovascular patients is also unclear. Methods We performed a systematic review and meta-analysis to comprehensively determine the prevalence and the prognostic role of NTIS in cardiovascular patients. The prevalence of NTIS was pooled using random-effect meta-analysis and the hazard ratios (HRs) for all-cause mortality, cardiac mortality and major adverse cardiovascular events (MACE) were also pooled. Results Forty-one studies were finally included. The pooled prevalence of NTIS in cardiovascular patients was 21.7% (95% CI 18.4%–25.3%). Subgroup by the types of cardiovascular diseases showed the prevalence of NTIS was highest in patients with heart failure (24.5%), followed by acute myocardial infarction (18.9%) and acute coronary syndrome (17.1%). Meta-analysis of studies using strict diagnostic criteria of NITS showed that the pooled prevalence of NTIS in cardiovascular patients was 17.6% (95% CI 14.5%–21.2%). NTIS was independently associated with increased risks of all-cause mortality (HR = 2.52, 95% CI 1.87–3.40, P < 0.001) and cardiac mortality (HR = 2.06, 95% CI 1.58–2.69, P < 0.001) in cardiovascular patients. NTIS was also an independent predictor of MACE in cardiovascular patients (HR = 1.73, 95% CI 1.32–2.26, P < 0.001). Conclusion NTIS is very common in patients with cardiovascular diseases. NTIS is an independent prognostic factor in cardiovascular patients and is associated with increased risks of all-cause mortality, cardiac mortality and MACE.
What problem does this paper attempt to address?